...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Eversana ValuationCaseStudy
6
Jan 03, 2022 11:00PM
1
DBS
Jan 04, 2022 08:42AM
3
Jan 04, 2022 01:16PM
2
Jan 04, 2022 02:32PM
6
Jan 07, 2022 04:36PM

"Why it's not happening is the million dollar question"

Do we need cash to incentivize participation? But how do you negotiate with participants in a hospitalized setting when time is of the essence in a life and death Covid-19 situation? 

Would it have been any easier in a non hospitalized setting? This is how the University of Minnesota went about it. Wondering if Pfizer's took the same approach for their double-blind non hospitalized study. 

https://www.parsemus.org/humanhealth/covid-19/covid-out-uminn/?gclid=EAIaIQobChMI7Y3Yn4qi9QIVcRFMCh3oJQ-vEAAYASAAEgI2G_D_BwE


Koo

10
Jan 08, 2022 11:30AM
11
Jan 08, 2022 12:52PM
9
Jan 08, 2022 01:18PM
6
Jan 09, 2022 12:20PM
10
Jan 09, 2022 12:37PM
6
Jan 09, 2022 06:29PM
2
Jan 10, 2022 08:36AM
Share
New Message
Please login to post a reply